EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Engineered Microvascular Model of the Blood–Brain–Tumor Barrier Reveals Endothelial Remodeling in Diffuse Midline Glioma

Kimberly R Bennett, Yann S Vanrobaeys, Tessy Teboh, Zakiya Smith, Anderson Scott, Cynthia Hajal, Paula T Hammond, Joelle P Straehla iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71474 ↗

At a glance

Journal article in Advanced Healthcare Materials, 2026. Written by Kimberly R Bennett and 7 co-authors. Institution: Harvard-MIT Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Major MEDLINE topics: Glioma, Blood-Brain Barrier, Brain Neoplasms, Microvessels. 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: Rally Foundation for Childhood Cancer Research, NCI NIH HHS, Howard Hughes Medical Institute.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Diffuse midline glioma (DMG) is a highly aggressive pediatric brain tumor that is difficult to treat because the blood–brain–tumor barrier (BBTB) prevents most drugs from reaching the tumor. A major obstacle for understanding this tumor‐vascular niche is the lack of a perfusable vascular model of DMG. To address this, we have established an in vitro model of the DMG‐BBTB, comprised of patient‐derived DMG tumor cells and primary human brain microvascular endothelial cells, astrocytes, and vascular pericytes, embedded in a fibrin matrix within a microfluidic chip. We report the development and characterization of self‐assembled microvascular networks, with consistent vasculature development across a range of tumor cell densities. Perfusion studies showed no significant alterations in vascular permeability when tumor cells were present. To elucidate transcriptomic changes, we employed scRNAseq on devices containing blood–brain barrier (BBB), DMG‐BBTB, or tumor necrosis factor alpha (TNFα)‐stimulated control. We observed significant differential gene expression between BBB and DMG‐BBTB, distinct from inflammatory signatures seen with TNFα perturbation. Our analysis indicated that DMG cells adopted a mesenchymal‐like phenotype, with further in silico studies predicting significant receptor‐ligand crosstalk between these cells and endothelium. In summary, we developed a high‐fidelity DMG‐BBTB model that recapitulates transcriptomic features of patient DMG microvasculature and features perfusable vasculature.

Subjects

MeSH terms (MEDLINE)

GliomaBlood-Brain BarrierBrain NeoplasmsMicrovesselsModels, BiologicalHumansEndothelial CellsPericytesCell Line, TumorTumor Necrosis Factor-alphaAstrocytesMicrophysiological SystemsCapillary Permeability

Author keywords

blood–brain barrierdiffuse midline gliomaorgan‐on‐a‐chippediatric neuro‐oncologytumor microenvironmenttumor–vascular nichevascular networks

Substances

Tumor Necrosis Factor-alpha

Authors and institutions

  • Harvard-MIT Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Biochemistry, Wellesley College, Wellesley, Massachusetts, USA.
  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Mechanical Engineering, Northeastern University, Boston, Massachusetts, USA.
  • Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, Washington, USA.

ORCID profiles: Joelle P Straehla

Funding

  • Rally Foundation for Childhood Cancer Research
  • NCI NIH HHS
  • Howard Hughes Medical Institute
  • The V Foundation for Cancer Research
  • MIT-Alfred P. Sloan University Center for Exemplary Mentoring
  • The Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Harvard Cancer Consortium
  • Ford Foundation
  • Cannonball Kids' Cancer Foundation

Cite

APA

Bennett, K. R., Vanrobaeys, Y. S., Teboh, T., Smith, Z., Scott, A., Hajal, C., Hammond, P. T., & Straehla, J. P. (2026). Engineered Microvascular Model of the Blood–Brain–Tumor Barrier Reveals Endothelial Remodeling in Diffuse Midline Glioma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71474

Vancouver

Bennett KR, Vanrobaeys YS, Teboh T, Smith Z, Scott A, Hajal C, et al. Engineered Microvascular Model of the Blood–Brain–Tumor Barrier Reveals Endothelial Remodeling in Diffuse Midline Glioma. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71474

BibTeX
@article{Bennett2026,
  author = {Bennett, Kimberly R and Vanrobaeys, Yann S and Teboh, Tessy and Smith, Zakiya and Scott, Anderson and Hajal, Cynthia and Hammond, Paula T and Straehla, Joelle P},
  title = {Engineered Microvascular Model of the Blood–Brain–Tumor Barrier Reveals Endothelial Remodeling in Diffuse Midline Glioma},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71474}
}
Start for free →